EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 11,000 shares, an increase of 44.7% from the February 13th total of 7,600 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily volume of 105,000 shares, the short-interest ratio is presently 0.1 days.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in EUDA Health stock. XTX Topco Ltd bought a new stake in EUDA Health Holdings Limited (NASDAQ:EUDA – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 16,463 shares of the company’s stock, valued at approximately $75,000. XTX Topco Ltd owned approximately 0.07% of EUDA Health as of its most recent filing with the Securities and Exchange Commission. 4.35% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Greenridge Global raised EUDA Health to a “strong-buy” rating in a research note on Monday, December 23rd.
EUDA Health Stock Performance
Shares of NASDAQ EUDA opened at $3.75 on Friday. EUDA Health has a 1-year low of $1.45 and a 1-year high of $6.30. The stock’s 50-day moving average is $3.90 and its two-hundred day moving average is $4.15.
About EUDA Health
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.
Further Reading
- Five stocks we like better than EUDA Health
- Most Volatile Stocks, What Investors Need to Know
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.